Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These conditions may directly promote tumour progression or predict other co‐morbid conditions such as cardiovascular disease that can further impair survival.47, 48, 49”
From Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment (2020) · cites this paper as [47]
In the citing paper
“Other studies suggest that visceral adipose tissue surface area is related to a higher inflammation and an adverse cardiometabolic risk profile.”
From Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment (2020) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Larsen, I. K., Småstuen, M., Johannesen, T. B., Langmark, F., Parkin, D. M., Bray, F., & Møller, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.037 · Cited by 848
Research works printed but not linked: 33
- 2010, OBESITY, 18, 1625, 10.1038/oby.2009.461 · DOI
- Lahmann, 2010, International journal of cancer. Journal international du cancer, 126, 2404, 10.1002/ijc.24952 · DOI · Paper page
- Soler, 1999, Hypertension, 34, 320, 10.1161/01.HYP.34.2.320 · DOI
- Lukanova, 2005, Cancer Epidemiology Biomarkers & Prevention, 14, 98, 10.1158/1055-9965.98.14.1 · DOI · Paper page
- 2009, International Journal of Epidemiology, 39, 660, 10.1093/ije/dyp186 · DOI · Paper page
- Bjorge, 2010, Cancer Epidemiology Biomarkers & Prevention, 19, 1737, 10.1158/1055-9965.EPI-10-0230 · DOI · Paper page
- 2010, American Journal of Epidemiology, 171, 892, 10.1093/aje/kwq006 · DOI · Paper page
- Lewington, 2002, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- Stocks, 2009, 6, e1000201, 10.1371/journal.pmed.1000201 · DOI · Paper page
- 2006, International Journal of Epidemiology, 35, 1570, 10.1093/ije/dyl233 · DOI · Paper page
- 2009, Statistics in medicine, 28, 1067, 10.1002/sim.3530 · DOI · Paper page
- Clarke, 1999, American Journal of Epidemiology, 150, 341, 10.1093/oxfordjournals.aje.a010013 · DOI · Paper page
- Emberson, 2004, European Journal of Cardiovascular Prevention & Rehabilitation, 11, 125, 10.1097/01.hjr.0000114967.39211.e5 · DOI · Paper page
- Whitlock, 2001, European journal of epidemiology, 17, 907, 10.1023/A:1016228410194 · DOI
- Barlow, 2009, Acta oncologica (Stockholm, Sweden), 48, 27, 10.1080/02841860802247664 · DOI · Paper page
- 2006, 49, 945, 10.1007/s00125-006-0207-6 · DOI · Paper page
- Eisenmann, 2008, 7, 17, 10.1186/1475-2840-7-17 · DOI · Paper page
- Franks, 2004, Diabetes Care, 27, 1187, 10.2337/diacare.27.5.1187 · DOI · Paper page
- Kahn, 2005, Diabetes Care, 28, 2289, 10.2337/diacare.28.9.2289 · DOI · Paper page
- 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 · DOI · Paper page
- Kahn, 2008, Lancet, 371, 1892, 10.1016/S0140-6736(08)60731-X · DOI
- 2008, International journal of obesity, 32, 304, 10.1038/sj.ijo.0803713 · DOI
- Unwin, 2006, JRSM, 99, 457, 10.1258/jrsm.99.9.457 · DOI
- Engeland, 2003, JNCI Journal of the National Cancer Institute, 95, 1244, 10.1093/jnci/djg010 · DOI · Paper page
- 2008, Cancer Epidemiology Biomarkers & Prevention, 17, 902, 10.1158/1055-9965.EPI-07-2524 · DOI · Paper page
- 2009, Annals of Oncology, 20, 1113, 10.1093/annonc/mdn736 · DOI
- Stolzenberg-Solomon, 2002, Cancer causes & control : CCC, 13, 417, 10.1023/A:1015729615148 · DOI
- Tornberg, 1986, New England Journal of Medicine, 315, 1629, 10.1056/NEJM198612253152601 · DOI
- 2010, The Oncologist, 15, 548, 10.1634/theoncologist.2009-0300 · DOI · Paper page
- 2006, American Journal of Epidemiology, 164, 769, 10.1093/aje/kwj284 · DOI · Paper page
- McKeown-Eyssen, 1994, Cancer Epidemiology Biomarkers & Prevention, 3, 687
- 2010, Journal of Clinical Oncology, 28, 4074, 10.1200/JCO.2010.27.9752 · DOI · Paper page
- Key, 2001, The Proceedings of the Nutrition Society, 60, 81, 10.1079/PNS200068 · DOI · Paper page
Cited by
Metabolic Syndrome and Risk of Cancer
Esposito, K., Chiodini, P., Colao, A., Lenzi, A., & Giugliano, D. (2012) · Diabetes Care · doi:10.2337/dc12-0336 · Cited by 1,209
Hagens, E. R. C., Feenstra, M. L., van Egmond, M. A., van Laarhoven, H. W. M., Hulshof, M. C. C. M., Boshier, P. R., Low, D. E., van Berge Henegouwen, M. I., & Gisbertz, S. S. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12540 · Cited by 65
Elevation of serum uric acid and incidence of type 2 diabetes: A systematic review and meta‐analysis
Xu, Y., Xu, K., Bai, J., Liu, Y., Yu, R., Liu, C., Shen, C., & Wu, X. (2016) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2016.09.003 · Cited by 49
Metadata
- Authors
- Bjorge, T., Lukanova, A., Tretli, S., Manjer, J., Ulmer, H., Stocks, T., Selmer, R., Nagel, G., Almquist, M., Concin, H., Hallmans, G., Jonsson, H., Haggstrom, C., Stattin, P., & Engeland, A.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-10-07
- Volume
- 40
- Issue
- 6
- Pages
- 1667-1677
- ISSN
- 0300-5771
- 1464-3685
- Cited by
- 47
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. https://app.cochat.ai/papers/10.1093/ije/dyr130
- The paper
- Bjorge, T., Lukanova, A., Tretli, S., Manjer, J., Ulmer, H., Stocks, T., Selmer, R., Nagel, G., Almquist, M., Concin, H., Hallmans, G., Jonsson, H., Haggstrom, C., Stattin, P., & Engeland, A. (2011). Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyr130
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.